Key result
In Turkish women, a 1-SD increment in height predicted a lower risk of all-cause death, whereas height was not associated with mortality in men.
Why the study?
Is short stature associated with increased risk of incident coronary heart disease and overall mortality in adults?
Cohort (n=3,394)
Yes
Is short stature associated with increased risk of incident coronary heart disease and overall mortality in adults?
Answers are grounded in this paper and cite their sources.
Short stature (below 160 cm) is an independent risk marker for all-cause mortality and tends to be a risk marker for incident coronary heart disease specifically in women, but not in men.
OBJECTIVE: We evaluated the associations of short stature with coronary heart disease (CHD) risk or overall mortality, which vary with sex and ethnicity/race. METHODS: Such associations were studied prospectively at a mean 13.5-years' follow-up in a population-based sample of 3394 Turkish adults (mean age 44±11 years) using Cox proportional hazards models. Covariates of height were sought in sex-specific tertiles. RESULTS: Height averaged 162.7±6.5 cm. Age-adjusted estimated marginal means for serum triglycerides, C-reactive protein and complement C3 in women (but not men) were significantly higher with decreasing height tertiles. In sex- and age-adjusted models, height was associated in men with neither incident CHD, nor death. In women, 1-SD increment (6.5 cm) in height only tended to marginal inverse association with CHD, but predicted significantly all-cause death (HR 0.83, 95% CI 0.59-0.98); HR attenuated only marginally after further adjustment for family income bracket, smoking status, alcohol usage, systolic blood pressure, serum high-density lipoprotein (HDL)- and non HDL-cholesterol. A threshold below 160 cm of female height doubled the adjusted risk of death compared to taller women. CONCLUSION: In contrast to men, short stature in Turkish women tends to be an independent risk marker for CHD, and height below 160 cm is a strong marker of death. Gender-specific early-life influences enhancing pro-inflammatory state may affect death and future CHD.
No takes yet. Share an insight, caveat, or question.
Onat et al. (2012) conducted a cohort in Coronary heart disease and overall mortality (n=3,394). 1-SD increment (6.5 cm) in height vs. Shorter stature was evaluated on All-cause death in women (HR 0.83, 95% CI 0.59-0.98). In Turkish women, a 1-SD increment in height predicted a lower risk of all-cause death, whereas height was not associated with mortality in men.
Synapse has enriched 10 related papers. Consider them for comparative context: